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Objectives: to examine the effect of reperfusion plasma and sICAM-1 on neutrophil integrin expression and neutrophil
adhesion to determine if sICAM-1 has a potential role in the regulation of neutrophil adhesion.
Materials: twenty-seven patients, 17 men and 10 women undergoing femorodistal surgery. Blood was taken preoperatively
and from the femoral vein following the release of the cross-clamp. Neutrophils were obtained from five volunteers and
incubated with phosphate buffered saline (PBS), preoperative plasma or reperfusion plasma with and without sICAM-1.
Neutrophil expression of CD11b and adhesion were measured.
Main results: neutrophil CD11b expression did not change following incubation in the three media. Neutrophil adhesion
increased significantly following exposure to reperfusion plasma compared to PBS or preoperative plasma (45.5 adhesion
vs. 12.75%, p<0.01 Mann–Whitney U-test). Soluble ICAM-1 decreased CD11b expression and adhesion in neutrophils
exposed to reperfusion plasma only (CD11b expression fell from 15.9 to 3.4 mcf, p<0.01 Mann–Whitney U-test and
adhesion fell to 11.6% cells adhered, p<0.01).
Conclusion: an increase in CD11b expression is not required for an increase in neutrophil adhesion. The change in
neutrophil adhesion produced by reperfusion plasma can be blocked by sICAM-1. Soluble ICAM-1 may have a physiological
role in the regulation of neutrophil adhesion.
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Introduction ligand for the neutrophil receptor CD11b/CD18. The
interaction of the endothelial integrin receptor ICAM-
There is a lot of evidence that demonstrates activation 1 with its polymorphonuclear (PMN) counter receptor
of neutrophils, endothelial cells and plasma factors Mac-1 (CD11b) is a vital step for normal PMN func-
during reperfusion.1,2 After ischaemic tissues such as tion.3,4 CD11b/CD18 binds to ICAM-1 through the
skeletal muscle are reperfused, systemic levels of the third immunoglobulin domain.5 Normally, the inte-
chemoactivating factors leukotriene B4, thromboxane grins are non-adhesive and need to be activated in
B2, platelet activating factor, and tumour-necrosis fac- order to become adhesive. The molecular mechanisms
tor are elevated. These mediators of inflammation underlying the activation of CD11b/CD18 are in-
induce systemic neutrophil activation which results in completely understood. Quantitative as well as qual-
upregulation of adhesion integrins on their surface, itative changes occur in these receptors after cellular
which enhances their attachment to the endothelium. activation. In unstimulated neutrophils, the CD11b
In addition to stimulating neutrophils, the cytokines polypeptide exists both on the cell surface and in far
released during reperfusion are thought to lead to greater quantities within an intracellular pool in the
activation of endothelium and upregulation of in- secondary and/or tertiary granules. After stimulation,
tercellular adhesion molecule-1 (ICAM-1), which in- contents of these granules are translocated to the cell
creases neutrophil adhesion. ICAM-1 is the endothelial surface, resulting in a 3- to 10-fold increase in surface
associated CD11b.6 It has been suggested that this
increase in surface expression may play an important*Abstract presented in part at the 83rd Surgical Research Society,
role in the mechanism of enhanced neutrophil ad-January 1996, Oxford.
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has therefore been postulated that CD11b/CD18 must of 44 years (range 28–56 years). Twenty millilitres
of peripheral venous blood were taken from eachundergo additional qualitative conformational
changes that facilitate adhesion. Recent im- volunteer on three separate occasions. The neutrophils
were isolated by centrifugation over layers of Hi-munochemical data has shown that the soluble form
of ICAM-1 (sICAM-1) is shed from in vitro activated stopaque 1119 and 1077 (Sigma Chemical Co., U.K.)
as described by English and Anderson and finallyendothelial cells into the culture supernatant and is
also present in the human circulation.8,9 The circulating resuspended in phosphate buffered saline at a con-
centration of 5·106 cells/ml.16form of ICAM-1 remains functionally active because
it is capable of inhibiting leucocyte function-associated
antigen-1 (LFA-1) dependent adhesion of lymphocytes
onto endothelium.10 However, the effect of sICAM-1
Neutrophil CD11b expressionon neutrophil–endothelial interactions has not been
investigated. Although the function of sICAM-1 in vivo
After separation neutrophils were then incubated inhas not been fully delineated, the presence of increased
either (i) Dulbecco’s Phosphate Buffered Saline (PBS)serum levels found in inflammatory and immune dis-
containing bovine serum albumin (1%), glucose (0.2%),orders compared with normal conditions suggests that
calcium chloride (1.8 mm) and magnesium chlorideit has a role in the regulation of the interaction between
(0.8 mm) (Sigma, Dorset, U.K.) as a control, or (ii)leucocytes and the cell surface form of the molecule.11–13
preoperative plasma or (iii) reperfusion plasma. TheIt has recently been shown that CD11b expression
cells were incubated at a final concentration offalls following revascularisation of an ischaemic limb
1·106 cells/ml for 30 min and neutrophil CD11b ex-and this has been associated with a fall in sICAM-
pression measured as previously described.12,15 The1 levels and neutrophil adhesion.14 This led to the
samples were analysed with a flow cytometer (Epics-hypothesis that the shed sICAM-1 binds to the neutro-
XL. Coulter Electronics, U.K.) using acquisition soft-phil CD11b integrin, blocking adhesion and producing
ware (XL. Coulter Electronics. U.K.) and the frequencyan apparent decrease in CD11b expression and plasma
distributions of the intensity of fluorescence from in-sICAM-1 concentration. This may provide a possible
dividual cells collected and expressed as mean channelphysiological role for sICAM-1, which may ultimately
fluorescence (mcf) units.have therapeutic potential.
The aim of this study was to examine (i) the in vitro
effect of reperfusion plasma on neutrophil integrin
expression and neutrophil adhesion and (ii) the effect Neutrophil adhesion
of sICAM-1 on the subsequent adhesion and integrin
expression in order to determine if sICAM-1 has a role After incubation for 30 min at 37 °C in PBS, pre-
in neutrophil function. This may ultimately lead to a operative plasma or reperfusion plasma, neutrophil
potential therapeutic application. adhesion was measured. The method used has been
described in detail by Santini et al. in which the alkaline
phosphatase activity of adherent cells is measured.16
Methods This method was chosen as it is a b2 integrin dependent
adhesion assay and suitable for examining the effect of
The protocol used in this study was approved by the sICAM-1 on neutrophil integrin dependent adhesion.
local ethics committee. Twenty-seven patients, 17 men Cell viability, determined by the exclusion of trypan
and 10 women with a median age of 72 years (range blue dye, was found to be 96% and 92.5% at the
54–82 years) undergoing elective femorodistal bypass beginning and end of the assay. The assay re-
surgery for chronic critical leg ischaemia were studied producibility provided an intra-assay coefficient of
prospectively. All patients had rest pain requiring variation <7% and inter-assay coefficient of variation
regular analgesia of more than 2 weeks’ duration <12%.
(median 6 weeks, range 3–10 weeks), none of the group
had evidence of tissue loss.15 The median cross-clamp
time was 55 min (range 40–70 min). Twenty millilitres
of blood were taken from the femoral vein pre- Measurement of sICAM-1 in plasma
operatively and within the first 5 min of cross-clamp
release. Preoperative and reperfusion plasma levels of sICAM-
1 were analysed by sandwich ELISA according to theNeutrophils were obtained from nine healthy vo-
lunteers, four women and five men with a median age instructions of the manufacturer (R&D Systems Europe
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Ltd.). The assay detection limit for sICAM-1 in the kit
was 0.35 ng/ml. The assay does not detect any known
cross-reactive antigens. The results are expressed as
nanograms per millilitre.
The effect of sICAM-1 on neutrophil adhesion
After incubation in PBS, preoperative plasma or re-
perfusion plasma the PMNs were added in 100 ll













with 50 ll of gelatin. At this stage increasing con-
centrations of sICAM-1 (R&D Systems Europe Ltd.) Fig. 1. Neutrophil CD11b expression following incubation. There
was no significant difference in the level of CD11b expressionwere added and the plate incubated in the usual
between the groups.manner for 30 min in 5% CO2 at 37 °C and neutrophil
adherence measured. Concentrations of sICAM-1 of
200 ng/ml have been found in normal donors9,19 with
an increase in level to 400 ng/ml found in vascular
patients14 and levels over 1000 ng/ml found in patients
with sepsis.20 The concentrations of sICAM-1 used
therefore incorporated this range.
The effect of sICAM-1 on neutrophil CD11b expression
Following incubation in PBS, preoperative plasma or
reperfusion plasma, again increasing concentrations





















and incubated for a further 30 min at 37 °C, and neutro-
Fig. 2. Neutrophil adhesion following 30 min incubation, with aphil CD11b expression determined. The final con- significant increase in adhesion following incubation with re-
centration of sICAM-1 used in these experiments perfusion plasma.
ranged from 0.4 to 4000 ng/ml.
and 15.9 mcf (IQR 8.9–17.5 mcf), respectively (Fig. 1).
There was no significant difference in the level of
CD11b expression between the groups (p>0.05, Mann–Results
Whitney U-test for all groups).
Results are expressed as medians and interquartile
ranges. The Mann–Whitney U-test was used as the
test of significance. The Wilcoxon’s signed rank sum Neutrophil adhesion
test was used for paired data.
The cells incubated in the suspension medium, PBS,
had a median neutrophil adhesion of 12.75% (IQR
5.5–17.5%). There was no significant difference be-
tween the control group and the neutrophils incubatedNeutrophil CD11b expression
in preoperative plasma, with this group demonstrating
a median adherence of 15.5% (IQR 6.7–17.9%) (p>0.05,After incubation in the suspension medium, PBS, the
level of CD11b expression was 15.1 mcf units (in- Mann–Whitney U-test). However, the neutrophils in-
cubated in reperfusion plasma showed an increase interquartile range 9.8–17.2 mcf). Following incubation
in the preoperative plasma and reperfusion plasma the median leucocyte adhesion to 45.5% (IQR 37.5–
55.6%) (p<0.01, Mann–Whitney U-test) (Fig. 2).the levels recorded were 14.5 mcf (IQR 9.2–16.5 mcf)
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Fig. 4. The effect of varying concentrations of sICAM-1 on neutrophilFig. 3. The effect of varying concentrations of sICAM-1 on neutrophil
CD11b expression following incubation with reperfusion plasma.adhesion following incubation in reperfusion plasma.
7.1–11.7, p<0.01 Mann–Whitney U-test) and this de-
creased further to 3.4 mcf (IQR 2.9–6.7, p<0.01 Mann–
sICAM-1 plasma concentration Whitney U-test) with 4000 ng/ml sICAM-1 (Fig. 4).
The preoperative concentration of sICAM-1 was
390 ng/ml (340–450 ng/ml), with the concentration in Discussion
the reperfusion sample being 175 ng/ml (135–210 ng/
ml). Neutrophils exposed to preoperative plasma did not
have increased CD11b expression or adhesion com-
pared to those incubated in the control suspension
media. They were also unaffected by increasing doses
of sICAM-1.The effect of sICAM-1 on neutrophil adhesion and CD11b
expression Neutrophils exposed to reperfusion plasma also
showed no change in CD11b expression, but they did
Neutrophils incubated with either the control sus- exhibit an increase in adhesion which was blocked by
increasing doses of sICAM-1.pension medium of PBS or preoperative plasma
showed no change in adhesion from their baseline The central role of the CD11b/CD18 membrane
glycoprotein subunit in adhesion dependent neutro-adhesion of 12.75% and 15%, respectively, after in-
cubation with increasing concentrations of sICAM-1. phil function is well documented.4,21,22 It has been
shown that cell surface expression of CD11b markedlyThe neutrophils incubated in reperfusion plasma
demonstrated a dose-dependent decrease in adhesion increases in response to neutrophil stimulation.6,17,23
This is associated with a concomitant decrease inwith increasing concentrations of sICAM-1. The fall in
adhesion became statistically significant at con- intracellular granule associated CD11b, indicating that
translocation from intracellular pools to the cell surfacecentrations of sICAM-1 of 400 ng/ml (22.3% adhesion
(22.5–31.25), p<0.01, Wilcoxon matched-pairs test) and occurs in response to stimulation. It has therefore been
suggested that increased surface expression of CD11bmaximum at 4000 ng/ml (11.6% adhesion (2.5–17.8),
p<0.001, Wilcoxon matched-pairs test) (Fig. 3). Neutro- might be the mechanism that enhances surface ad-
hesiveness.5,24 However, neutrophils exposed to re-phils incubated with PBS or preoperative plasma
showed no change in CD11b expression after in- perfusion plasma exhibited significantly increased
adhesion without an increase in CD11b surface ex-cubation with sICAM-1 up to a concentration of
4000 ng/ml, 15.1 mcf vs. 14.9 mcf (IQR 8.7–16.9) for pression. This implies that quantitative surface re-
cruitment of CD11b from cytoplasmic granules is notcells in PBS with and without sICAM-1 and 14.5 mcf
vs. 15.3 mcf (IQR 9.6–15.9) for cells in preoperative the mechanism of enhanced neutrophil adhesion. This
conclusion that increased surface expression of CD11bplasma. Neutrophils incubated in reperfusion plasma
showed a significant decrease in CD11b expression is not causally related to increased adhesiveness is
supported by the recent observations that granulocyte–with 400 ng/ml of sICAM-1, 15.9 mcf vs. 9.9 mcf (IQR
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monocyte colony stimulating factor increases the sur- is not required for neutrophil adhesion, a fall may be
responsible for the decrease in adhesion. It has alsoface expression of CD11b but does not promote
been demonstrated that sICAM-1 concentration fallsadhesion to the endothelium.25 Further support comes
during this time period.14 This may be explained byfrom the observations that neutrophil cytoplasts dis-
the theory that the shed endothelial sICAM-1 receptorplay increased adherence to endothelium when stim-
binds to the neutrophil CD11b integrin thus blockingulated, despite the fact that they do not increase surface
adhesion and producing an apparent decrease in PMNexpression of CD11b.26,27 These data all indicate that
CD11b expression and plasma sICAM-1 concentration.the quantitative increase in surface expression of
The high levels of sICAM-1 found in some conditionsCD11b that follows stimulation is neither sufficient
may represent the body’s response to regulate neutro-nor necessary to increase neutrophil adherence to
phil–endothelial cell interaction. Elucidation of theendothelium. Neutrophil adhesion may not involve
mechanisms that govern neutrophil adherence tothe CD11b complex after reperfusion. Fibrinogen has
endothelium, therefore, may be crucial to our abilitybeen shown to mediate leucocyte adhesion to vascular
to alter therapeutically neutrophil-mediated in-endothelium through an ICAM-1 dependent path-
flammation and tissue injury.way.28 However, several studies have shown that
monoclonal antibodies to CD11b have prevented
neutrophil adhesion during reperfusion with a de-
crease in lung injury.29,30 This suggests the possibility References
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